Serena Maria Boccia

4PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 10, 2024
Effects of niraparib dose reduction on short-term outcomes in ovarian cancer patients.

Matteo Bruno, Adriana Ionelia Apostol, Serena Maria Boccia

|May 28, 2024
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival?

Carolina Maria Sassu, Claudia Marchetti, Giorgia Russo

|Feb 09, 2023
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors.

Lucia Musacchio, Serena Boccia, Claudia Marchetti

|Dec 23, 2022
Trabectedin plus pegylated liposomal doxorubicin in patients with disease progression after PARP inhibitor maintenance: a real-life case-control study.

Laura Vertechy, Serena Maria Boccia, Giordana Tiberi

Pageof 1

Frequent Collaborators

4 joint publications

Anna Fagotti

4 joint publications

Giovanni Scambia

2 joint publications

Angelo Minucci

2 joint publications

Claudia Marchetti